Jan‐Anders Karlsson

609 total citations
15 papers, 492 citations indexed

About

Jan‐Anders Karlsson is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jan‐Anders Karlsson has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Physiology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jan‐Anders Karlsson's work include Asthma and respiratory diseases (8 papers), Phosphodiesterase function and regulation (4 papers) and Ion channel regulation and function (3 papers). Jan‐Anders Karlsson is often cited by papers focused on Asthma and respiratory diseases (8 papers), Phosphodiesterase function and regulation (4 papers) and Ion channel regulation and function (3 papers). Jan‐Anders Karlsson collaborates with scholars based in Sweden, United Kingdom and Denmark. Jan‐Anders Karlsson's co-authors include David Raeburn, C. G. A. Persson, Adrian Tomkinson, John E. Souness, Stephen E. Webber, Malcolm N. Palfreyman, Michael J. Ashton, Miriam Griffin, Karen Ebsworth and Kenneth H. Pollock and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Pharmacology & Therapeutics.

In The Last Decade

Jan‐Anders Karlsson

15 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Anders Karlsson Sweden 10 314 197 91 83 81 15 492
Winston S. Marshall United States 10 220 0.7× 213 1.1× 65 0.7× 56 0.7× 82 1.0× 20 564
Stephanie S. Tucker United States 11 180 0.6× 300 1.5× 158 1.7× 70 0.8× 77 1.0× 20 504
Lynn E. Rinkema United States 13 136 0.4× 252 1.3× 111 1.2× 87 1.0× 100 1.2× 28 573
C. S. McFarlane Canada 14 199 0.6× 288 1.5× 100 1.1× 71 0.9× 135 1.7× 20 619
G. Muačević Germany 7 134 0.4× 133 0.7× 56 0.6× 88 1.1× 49 0.6× 19 455
Marwa N. Samhoun United Kingdom 12 136 0.4× 428 2.2× 205 2.3× 71 0.9× 174 2.1× 19 674
Kazuaki Naito United States 11 168 0.5× 102 0.5× 41 0.5× 52 0.6× 26 0.3× 32 347
Stephen L. Underwood United Kingdom 12 171 0.5× 292 1.5× 222 2.4× 123 1.5× 41 0.5× 16 588
T. Hesselbo United Kingdom 5 180 0.6× 102 0.5× 62 0.7× 145 1.7× 79 1.0× 9 584
Edward J. Kusner United States 10 120 0.4× 209 1.1× 84 0.9× 89 1.1× 68 0.8× 15 402

Countries citing papers authored by Jan‐Anders Karlsson

Since Specialization
Citations

This map shows the geographic impact of Jan‐Anders Karlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Anders Karlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Anders Karlsson more than expected).

Fields of papers citing papers by Jan‐Anders Karlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Anders Karlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Anders Karlsson. The network helps show where Jan‐Anders Karlsson may publish in the future.

Co-authorship network of co-authors of Jan‐Anders Karlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Anders Karlsson. A scholar is included among the top collaborators of Jan‐Anders Karlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Anders Karlsson. Jan‐Anders Karlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Webber, Stephen E., et al.. (1997). IFN-Gamma Production from Human Th1 Cells Is Controlled by Raf Kinase. International Archives of Allergy and Immunology. 113(1-3). 275–278. 5 indexed citations
2.
Souness, John E., Miriam Griffin, Karen Ebsworth, et al.. (1996). Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer. British Journal of Pharmacology. 118(3). 649–658. 104 indexed citations
3.
Ashton, Michael J., Christopher Lawrence, Jan‐Anders Karlsson, et al.. (1996). Anti-inflammatory 17β-Thioalkyl-16α,17α-ketal and -acetal Androstanes:  A New Class of Airway Selective Steroids for the Treatment of Asthma. Journal of Medicinal Chemistry. 39(25). 4888–4896. 35 indexed citations
4.
Webber, Stephen E., Martyn Foster, David Raeburn, et al.. (1995). Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP‐specific phosphodiesterase: comparison with rolipram. British Journal of Pharmacology. 115(1). 39–46. 69 indexed citations
5.
Raeburn, David, Stephen L. Underwood, S.A. Lewis, et al.. (1994). Anti‐inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. British Journal of Pharmacology. 113(4). 1423–1431. 83 indexed citations
6.
Raeburn, David, John E. Souness, Adrian Tomkinson, & Jan‐Anders Karlsson. (1993). Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: Biochemistry, pharmacology and therapeutic potential in asthma. Birkhäuser Basel eBooks. 40. 9–32. 34 indexed citations
7.
Tomkinson, Adrian, Jan‐Anders Karlsson, & David Raeburn. (1993). Comparison of the effects of selective inhibitors of phosphodiesterase types III and IV in airway smooth muscle with differing β‐adrenoceptor subtypes. British Journal of Pharmacology. 108(1). 57–61. 40 indexed citations
8.
Raeburn, David & Jan‐Anders Karlsson. (1991). Potassium channel openers: Airway pharmacology and clinical possibilities in asthma. Birkhäuser Basel eBooks. 37. 161–180. 11 indexed citations
9.
Karlsson, Jan‐Anders, et al.. (1991). Cigarette smoke‐induced changes in guinea‐pig airway responsiveness to histamine and citric acid. Acta Physiologica Scandinavica. 142(1). 119–125. 7 indexed citations
10.
Salmon, John A., L.G. Garland, J. William Costerton, et al.. (1991). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Birkhäuser Basel eBooks. 1 indexed citations
11.
Karlsson, Jan‐Anders, et al.. (1990). Rapid Clearance of Xanthines from Airway and Pulmonary Tissues. American Review of Respiratory Disease. 141(5_pt_1). 1167–1171. 8 indexed citations
12.
Karlsson, Jan‐Anders & C. G. A. Persson. (1989). Novel peripheral neurotransmitters and control of the airways. Pharmacology & Therapeutics. 43(3). 397–423. 12 indexed citations
13.
Nielsen‐Kudsk, Jens Erik, Jan‐Anders Karlsson, & C. G. A. Persson. (1986). Relaxant effects of xanthines, a β2-receptor agonist and Ca2+ antagonists in guinea-pig tracheal preparations contracted by potassium or carbachol. European Journal of Pharmacology. 128(1-2). 33–40. 20 indexed citations
14.
Björkman, Sven, Tommy Lewander, Jan‐Anders Karlsson, Lars‐Owe Koskinen, & Tyra Zetterström. (1981). Thermic and tremorogenic effects of thyroliberin (TRH) in reserpine-treated mice—the non-involvement of GABA-ergic mechanisms. Journal of Pharmacy and Pharmacology. 33(1). 580–585. 7 indexed citations
15.
Karlsson, Jan‐Anders & C. G. A. Persson. (1981). INFLUENCE OF TRACHEAL CONTRACTION ON RELAXANT EFFECTS in vitro OF THEOPHYLLINE AND ISOPRENALINE. British Journal of Pharmacology. 74(1). 73–79. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026